Lenalidomide
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='4tz4' size='340' side='right' caption='Crystal Structure of Human Cereblon in Complex with DDB1 and Lenalidomide ([[4tz4]])' scene='95/954025/Cv/2'> | <StructureSection load='4tz4' size='340' side='right' caption='Crystal Structure of Human Cereblon in Complex with DDB1 and Lenalidomide ([[4tz4]])' scene='95/954025/Cv/2'> | ||
| - | Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). | + | Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). See also [https://en.wikipedia.org/wiki/Lenalidomide]. |
| + | |||
| + | On a molecular level, <scene name='95/954025/Cv/3'>lenalidomide has been shown to interact with the ubiquitin E3 ligase cereblon</scene> and target this enzyme to degrade the Ikaros transcription factors IKZF1 and IKZF3. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 13:21, 26 February 2023
| |||||||||||
